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A B S T R A C T
Purpose: During incremental atrial pacing in patients with atrioventricular nodal reentrant tachycardia, the PR
interval often exceeds the RR interval (PR > RR) during stable 1:1 AV conduction. However, the PR/RR ratio
has never been evaluated in a large group of patients with pacing from the proximal coronary sinus and after
isoproterenol challenge. Our study validates new site of pacing and easier method of identiﬁcation of PR > RR.
Material and methods: A prospective protocol of incremental atrial pacing from the proximal coronary sinus was
carried out in 398 patients (AVNRT-228 and control-170). The maximum stimulus to the Q wave interval (S-
Q=PR), SS interval (S-S), and Q-Q (RR) interval were measured at baseline and 10min after successful slow
pathway ablation and after isoproterenol challenge (obligatory).
Results: The mean maximum PR/RR ratios at baseline were 1.17 ± 0.24 and 0.82 ± 0.13 (p < 0.00001) in
the AVNRT and controls respectively. There were no PR/RR ratios ≥1 at baseline and after isoproterenol
challenge in 12.3% of the AVNRT group and in 95.9% of the control group (p < 0.0001). PR/RR ratios≥1 were
absent in 98% of AVNRT cases after slow pathway ablation/modiﬁcation in children and 99% of such cases in
adults (P=NS). The diagnostic performance of PR/RR ratio evaluation before and after isoproterenol challenge
had the highest diagnostic performance for AVNRT with PR/RR > =1 (sensitivity: 88%, speciﬁcity: 96%, PPV-
97%, NPV-85%).
Conclusions: The PR/RR ratio is a simple tool for slow pathway substrate and AVNRT evaluation. Eliminating
PR/RR ratios ≥1 may serve as a surrogate endpoint for slow pathway ablation in children and adults with
AVNRT.
1. Introduction
Atrioventricular (AV) nodal reentrant tachycardia (AVNRT) is the
most common form of paroxysmal regular supraventricular tachycardia
in pediatric and adult patients referred for invasive electrophysiological
study and catheter ablation (CA) [1–4]. The presence of dual AV nodal
physiology (DAVN) is typically reported as a substrate for AVNRT. The
classical deﬁnition of DAVN is an atrio-His (AH) jump greater than
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50ms with a 10-ms decrement in A1A2. However, this condition is only
met in approximately half of pediatric patients with AVNRT [4].
Moreover, criteria for DAVN have been reported in up to 44% of pa-
tients without AVNRT, especially in the pediatric population [4–9]. In
patients with AVNRT, however, DAVN is documented less often than
sustained slow pathway conduction (SSPC) during incremental atrial
pacing (IAP). In patients with AVNRT and a fast rate of IAP, the PR
interval often exceeds the RR interval (PR/RR > 1) during stable 1:1
AV conduction. This phenomenon could be a substrate for the in-
ducibility of AVNRT, and its absence could be a marker of slow pathway
ablation or modiﬁcation [6–9].
SSPC has never been evaluated in such a way in a large, unselected
group of patients (more than 100) with AVNRT. Moreover, there has
been no prospective study on a simpliﬁed approach for evaluating SSPC
with pacing from the proximal coronary sinus (PCS) at baseline and
when needed after isoproterenol infusion. Previous studies involved
only the high right atrium pacing site and IAP with several PR intervals
exceeding the RR interval with stable 1:1 AV conduction (Table 1)
[4–9].
The aim of our study is to characterize the baseline and post-abla-
tion AV nodal conduction features during IAP from the PCS in un-
selected pediatric and adult patients with AVNRT. We also compared
our ﬁndings to a control population of patients without AVNRT. The
results show that the simpliﬁed approach for SSPC evaluation could be
a simple, fast, and accurate technique for AVNRT diagnosis and end-
point of SP ablation or modiﬁcation.
SP ablation was deﬁned as lack of dual atrioventricular physiology
and non-inducibility of AVNRT. SP modiﬁcation was deﬁned as non-
inducibility of AVNRT with residual jump and/or single echo beat.
2. Material and methods
Data were collected from a prospective multicenter registry that
covers procedures from six centers. Patients were recruited between
2010 and 2013. The intracardiac signals and measurements shown in
Figs. 1 and 2 were obtained from procedures performed in the year
2016. All of the patients investigated had been referred for electro-
physiological study and radiofrequency catheter ablation. A prospective
protocol of IAP was carried out in 398 patients who were referred for
ablation due to documented AVNRT (n=228, study group) and other
non-SP-dependent arrhythmias (control, n= 170).
All patients in the AVNRT group had documented narrow QRS ta-
chycardia prior to EPS. In the control group, 70 patients with accessory
pathway had orthodromic tachycardia, 24 patients had atrial ﬂutter
(narrow QRS), and 10 patients had atrial tachycardia. Therefore,
narrow QRS tachycardia was documented in 104 patients in the control
group. The study protocol complies with the Declaration of Helsinki
and was approved by 2 local Institutional Review Boards: 1) Bioethics
Committee of the Regional Specialist Hospital, Centre for Research and
Development in Wroclaw, Poland (approval number KB/2/2010, 2
June 2010); 2) Bioethics Committee of the Swietokrzyska Chamber of
Physicians and Dentists in Kielce, Poland (approval number 6/A/2009,
9 February 2009). All patients gave informed consent prior to the
procedure. Antiarrhythmic drugs were discontinued for a minimum of 5
half-lives prior to the study.
2.1. Electrophysiological study and ablation
Minimally invasive non-ﬂuoroscopic imaging and catheter ablation
were performed with minimum ﬂuoroscopy exposure (4–8 frames/s) or
non-ﬂuoroscopic navigation and imaging. A detailed description of the
approach is reported in previous studies [10,11]. Shortly, the left
anterior oblique view (or biplane left and right anterior oblique view
for the MINI CA approach) was used to assess the catheter position and
electroanatomical mapping. An EP-tracer (EP Recording System, Car-
dioTek, Maastricht, the Netherlands) was used for all procedures to
record the input from all 12 electrocardiography (ECG) leads and in-
tracardiac signals simultaneously. Under ﬂuoroscopic or non-ﬂuoro-
scopic guidance, a decapolar catheter was placed in the coronary sinus,
and one mapping/ablation catheter was positioned using a “dynamic
approach” in the His bundle region, PCS, right atrium, and right ven-
tricle. The catheter was either a 4 or 8-mm gold tip catheter (Biotronik),
a 4-mm platinum-iridium catheter (St. Jude Medical, St. Paul, Minn.,
USA), or an 8-mm gold tip catheter (Osypka AG, Germany).
A three-dimensional electroanatomical system (3D-EAM, Ensite
Velocity, St. Jude Medical) was used according to the discretion of the
treating physician or the availability in the center. Bipolar intracardiac
electrograms were ﬁltered between 40 and 500 kHz and recorded at
100mm/s. All pacing maneuvers from the ventricle or atrium were
performed at a minimum of twice the diastolic threshold using a pro-
grammable stimulator built into the recording system.
Electrophysiological measurements were obtained in the baseline
Table 1
Comparison of previous and simpliﬁed approaches for PR/RR ratio measurement.
Authors Baker et al. [6] Kannankeri et al. [9] Blurton et al. [8] Martinez-Sanchez et al.
[7]
Sledz et al.
(present study)
AVNRT (n) 30 61 92 85 228
Control (n) 27 0 46 56 170
Pacing site HRA HRA HRA HRA PCS
Children< 18 (%) 0 90 100 0 26
DAVN by only A2H2 evaluation (S2, Jump value) Yes (ND) YES (≥50 ms) YES (≥40 ms) YES (≥50 ms) NO (S2, S3 or S4≥ 50
ms)
PR/RR ratio≥ 1 accepted only in 1 beat no, continuous stable for
15 s
no, continuous no, continuous no, continuous yes
Isoproterenol challenge when neccessary for induction no yes yes yes yes
Isoproterenol challenge and PR>RR measurement in
all cases after ablation
no no no no yes
Catheters (number) 4 4 3 3 2
General anesthesia (% of patients) 0 0 > 50 0 0
PR > RR in AVNRT(%) 93 93 60 78 88
PR > RR in controls (%) 11 ND 13 12 4
% of standard „jump” in AVNRT 57 52 42 61 49
% of standard „jump” in controls 11 ND 30 18 9
Abbreviations: AVNRT – atrioventricular nodal reentrant tachycardia; HRA – high right atrium; PCS –k proximal coronary sinus; DAVN – dual AV nodal (physiology); A2H2 – atrial
potential after premature extrastimulus; S2 – the ﬁrst premature extrastimulus after train (S1); ND – not declared; S3 – the second premature extrastimulus after S2 and train; S4 – the
third premature extrastimulus after S2, S3 and train; PR/RR ratio – PR interval to RR interval ratio: from the atrial stimulus to earliest R wave on ECG during incremental atrial pacing;
PR>RR – the PR interval often exceeds the RR interval.
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state. When necessary for tachycardia induction isoproterenol were
administered and measurements were repeated after administering an
ultra-rapid intravenous bolus of isoproterenol via the peripheral route
at an initial dose of 0.01–0.03mg (0.2mg/mL, 0.5–1mL of a 1:50000
dilution), which was repeated within 3min when necessary to increase
the sinus rhythm to higher than 30% of the baseline state and at least
100 bpm. The ﬁnal protocol of arrhythmia induction was performed
after intravenous bolus administration of 1mg of atropine.
Radiofrequency energy was delivered in temperature-control mode
using an EP-Shuttle Generator (Stockert, Biosense Webster, Cordis, Bar
Diamond, Calif., USA) to the target area with a power output of
50–60W and a temperature of 60 °C.
For slow pathway ablation, short pulses of radiofrequency energy
were applied continuously with a maximum 8 continuous junctional
beats. All patients achieved at least 15 junctional beats in the AVNRT
group. None of the patients in the AVNRT group required left-sided
ablation. When junctional beats were not induced during 15 s of
radiofrequency application, further application at this site was stopped,
and the ablation catheter was repositioned.
2.2. Simpliﬁed approach for electrophysiological measurement
IAP involved automatic performed pacing from only the PCS.
During IAP maximum values of the PR interval, Wenckebach point, and
RR interval were validated. The PR interval was calculated from the
pacing spike to the ﬁrst deﬂection of the QRS complex (stimulus to Q
wave interval= PR interval) with consistent 1:1 AV conduction
measurement prior to the Wenckebach point. The PP interval (stimulus
to stimulus) prior to AV Wenckebach was measured. The RR interval
was calculated between the ﬁrst deﬂections of QRS complexes prior to
the Wenckebach point. The standard pacing protocols included auto-
mated IAP (pre-deﬁned from the pacer conﬁguration) with a decrease
of 10ms every 2 s the atrial or atrioventricular node refractory period.
Programmed atrial and ventricular stimulation with S1S2 was ty-
pically performed. Therefore, a standard jump was documented as a PR
interval “jump” greater than 50ms with a 10-ms decrement in S1S2.
However, when necessary for the induction or documentation of a PR
jump, up to four drive trains including 8 beats (500, 400, 350, 300
msec) and up to three extra stimuli (S2, S3, S4) tests were employed
[11,12]. Therefore, a combined jump was documented as a PR interval
jump greater than 50ms with a 10-ms decrement in S1S2, S2S3, or
S3S4.
To detect the onset of the QRS, we used the earliest ventricular wave
from surface lead II. The AH, HV, VA, and SA intervals were also
measured for diﬀerential diagnosis during the sinus rhythm and sus-
tained tachycardia by dynamic repositioning of the ablation catheter in
the AVN region. Detailed analysis of the reasons for PR/RR < 1 during
IAP is reported prospectively. The presence of DAVN before and after
ablation was also assessed. After ablation, measurements were repeated
10–15min after successful ablation and performed after isoproterenol
administration in all patients.
For the diagnostic deﬁnition of a standard jump, an increase in AH
by 50ms for a 10-ms decrement in A1–A2 coupling interval indicates
increase in the PR interval by 50ms for a 10-ms decrement in S1–S2,
Fig. 1. Electrocardiograph measurements during incremental atrial pacing from PCS in patients with AVNRT (familial form of AVNRT in mother and daughter) prior to ablation of SP.
Five standard ECG leads (I, II, III, V1, V6) and ﬁve leads from a decapolar catheter were located in coronary sinus (CS) CS 1 2, CS 3 4, CS 5 6, CS 7 8, CS 9 10. In the PCS (CS 9 10), there
are three ablation catheter leads: Abl dys (ablation 1–2 distal bipolar), ABL pro (ablation 3–4 proximal bipolar), and UNI (unipolar from ablation 1). Standard PR, RR, and RR interval
measurements were done with a paper speed of 50mm/s. The black arrow represents the pacing spike, which is visible in the front of the QRS complex. PR intervals with a star (“*”)
represent PR intervals longer than the RR interval. “〒” represents pacing spikes that are not conducted to the ventricle due to refractoriness of the SP. An PR interval with “@” represents
the maximum PR/RR ratio. Note that at least the last 5 PR intervals are longer than the RR intervals. Max PR (PR@)=580 msec, max RR=430 msec, max PP=360 msec. Max PR/max
RR=1.35. Note that during IAP, two sudden prolongations of PR > 50 msec occurred: pacing spikes 6 and 11.
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while combined jump includes an increase in the PR interval by 50ms.
SSPC was deﬁned as the ability to conduct two impulses from PCS
pacing in succession. These deﬁnitions were obtained from previous
studies. The jump was deﬁned as repeatedly conﬁrmed increments of a
minimum of 50ms in the PR interval in response to a 10-ms decrement
after S2 (standard) and after S2S3, or S3S4 (combined). Examples of
these measurements are presented in Figs. 1–3. For electrophysiological
measurements, the recorded tracings were measured oﬀ-line by two
investigators (J.Sl. and S.S.).
2.3. Diﬀerential diagnosis of supraventricular tachycardia with simpliﬁed 2-
catheter approach
A detailed description of the simpliﬁed two-catheter and MINI CA
approach was reported in previous studies, which included DAVN and
VA interval evaluation, the atrial activation sequence during supra-
ventricular tachycardia (SVT) and right ventricular overdrive pacing
(RVOP), the response to RVOP (PPI-TCL evaluation), and exclusion of
other possible mechanisms of SVT [11–13]. Moreover, when the diag-
nosis was uncertain, additional techniques or 3D mapping were per-
formed to validate the atrial activation pattern. The site of successful
radiofrequency energy application was used in combination with the
diagnostic techniques to conﬁrm the mechanism of SVT [4].
2.4. Statistical analysis
The results are presented as the mean ± standard deviation (SD).
Continuous variables were compared using an unpaired t-test. A P
value<0.05 was considered signiﬁcant. The sensitivity, speciﬁcity,
positive and negative predictive values, and accuracy were calculated
using standard deﬁnitions. Data were analyzed using Stata version 10
(Stata Statistical Software, Release 10, College Station, Tex., USA; Stata
Corporation LP 2007).
3. Results
3.1. Patient population
The AVNRT group consisted of 228 pediatric and adult patients
(age: 39.9 ± 20.7 years; 67% women; children (age < 18): 26%),
while the control group consisted of 170 pediatric and adult patients
(age: 37.6 ± 22.4 years (p=NS); 43% women (P < 0.05); children:
26% (P=NS)). The control group underwent invasive electro-
physiological studies for accessory pathways (n=117), atrial ﬂutter
(n= 24), atrial tachycardia (n=10), and idiopathic ventricular ta-
chycardia (n= 20). One patient from the control group had idiopathic
ventricular tachycardia and orthodromic tachycardia. Ultimately, 226/
228 AVNRT patients were successfully ablated (Table 2).
Structural heart disease were deﬁned as any signiﬁcant heart or
valvular diseases associated with limitation of antiarrhythmic treat-
ment (left ventricular hypertrophy, dilated cardiomyopathy, signiﬁcant
valvular heart disease). They were present in 4.6% of the patients in the
AVNRT group and 9.4% of the control group (P < 0.05). The mean
ejection fraction was above 60% in both groups (P=NS). In the
AVNRT group, 99% (226/228) of the cases were successfully ablated,
while the rate was 92% (156/170) in the control group. There were 6
cases of redone procedures in the AVNRT group and 12 redone or
second procedures (for the second substrate) in the control group. There
Fig. 2. Electrocardiograph measurements during IAP from PCS in patients with AVNRT prior to ablation of SP. There is induction of typical slow-fast AVNRT with a very long max PR
interval after isoproterenol challenge. The external and intracardiac leads and symbols are similar to those shown in Fig. 1. Note that at least 8 PR intervals are longer than RR intervals.
There are 8 pacing spikes preceeding the QRS complex. Max PR (PR@)=750 msec, max RR=490 msec, max PP=350. Max PR/max RR=1.53. The last pacing was not conducted due
to induction of slow-fast AVNRT. Note that during IAP, three sudden prolongations of PR > 50 msec occurred: pacing spikes 2, 8, and 10.
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were no severe cardiovascular complications associated with the pro-
cedures.
3.2. Sustained slow pathway conduction before and after ablation
Induction of slow-fast AVNRT prior to ablation was documented in
210 cases in the AVNRT group. There were 168 patients with induction
of slow-fast AVNRT with a “jump” and 42 patients with slow-fast
AVNRT induction without a jump. Induction of fast-slow AVNRT with a
jump was documented in only 4 cases (and simultaneously with slow-
fast AVNRT in 2 cases). In one patient two types of AVNRT were in-
duced: slow-slow AVNRT and typical slow-fast AVNRT.
Despite the administration of several boluses of isoproterenol and
ﬁnally 1mg of atropine, 12 patients showed no induction of AVNRT but
showed dual atrioventricular physiology (standard or combined jump).
These patients had documented paroxysmal regular narrow QRS ta-
chycardia with typical ECG of AVNRT. In 2 cases, there was no re-
producible induction of AVNRT nor a jump, but the baseline PR/RR
ratio was>1. In these 2 cases SSPC was the only indicator and end-
point for ablation.
In the AVNRT and control groups, the mean maximum PR/RR ratios
at baseline were 1.17 ± 0.24 (median: 1.19; min-max: 0.50–1.74; 1 st
and 3rd quartiles: 1.05 and 1.33) and 0.82 ± 0.13 (median: 0.83; min-
max: 0.37–1.2; 1 st and 3rd quartiles: 0.75 and 0.91, p < 0.00001),
respectively. At baseline, a PR/RR ratio ≥1 (at least one PR interval
longer than the RR interval) during IAP from PCS was documented in
76.3% of the patients with AVNRT and in only 2.3% of patients from
the control group (p < 0.0001). Moreover, isoproterenol challenge
increased the incidence of PR/RR ratios ≥1 from 76.3% to 87.7%
(p < 0.01) in the AVNRT group. In contrast, isoproterenol infusion did
not signiﬁcantly increase the value in the control group (2.3%–4.1%,
p=NS).
At baseline, a standard jump after S2 and combined jump after S2,
S3, or S4 was documented in 112/228 (49%) and 170/228 (74.5%,
p < 0.05) AVNRT patients. After isoproterenol infusion, a standard
jump and combined jump was documented in 7 more cases and 12 more
cases of AVNRT (after S2: 52% (119/228), P > 0.05, and after S2, S3
and/or S4: 79.8% (182/228), P < 0.05, respectively). The absence of
PR/RR≥ 1 during IAP at baseline and after isoproterenol challenge
prior to ablation was found in 12.3% (28/228) of the AVNRT group and
95.9% (163/170) of the control group (p < 0.0001). Standard and
combined jumps were observed in 8.8% (16/170) and 8.8% (20/170) of
Fig. 3. Electrocardiograph measurements during incremental atrial pacing from PCS in patient with AVNRT after ablation of SP. The external and intracardiac leads and symbols are
similar those in Fig. 1. Note that all PR intervals are shorter than RR intervals. Max PR (PR@)=260 msec, max RR=350 msec, max PP=350. Max PR/max RR=0.74. Eight pacing
spike were not conducted due to a lack of continuous conduction via SP. No sudden prolongation of PR > 50 msec with a similar PP max (Wenckebach point) shows improvement of fast
pathway conduction after SP ablation. The last pacing was not conducted due to the refractory period of the fast pathway and a lack of continuous SP conduction. Similar PR/RR ratio
(below 1) were calculated following the isoproterenol challenge after SP ablation. At baseline and after isoproterenol challenge PR/RR ratio was> 1, but after ablation of SP region PR/
RR < 1 were recorded in these cases (a 36-year-old mother and her 14-year-old daughter) during the same-day procedure for the familial form of slow-fast AVNRT.
Table 2
General characteristics.
AVNRT
(n=228)
Control
(n=170)
P value
Age (year) 39.9 ± 20.7 37.6 ± 22.4 NS
Women (%) 67.0 43.0 p < 0.05
Children (%) 26.0 26.0 NS
Structural heart disease (%) 4.6 9.6 p < 0.05
Diabetes (%) 10.0 12.9 NS
Hypertension (%) 24.5 24.7 NS
Smoking (%) 10.5 11.7 NS
Abbreviations: AVNRT – atrioventricular nodal reentrant tachycardia; NS – non-sig-
niﬁcant.
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the control group. After isoproterenol challenge, these numbers in-
creased to 12.9% (22/170) and 14.7% (25/170). Among the 46 AVNRT
patients with no combined jump at baseline and after isoproterenol
challenge, a standard jump and combined jump were present in 26.1%
(12/46) and 36.9% (17/46) after ablation, respectively.
The diagnostic performance of PR/RR ratio evaluation prior or after
isoproterenol challenge had the highest diagnostic performance for
AVNRT with PR/RR > =1 (sensitivity: 88%, speciﬁcity: 96%, PPV
(positive predictive value): 97%, NPV (negative predictive value): 85%
(Table 3). The following mechanisms were documented for the absence
of PR/RR≥ 1 during IAP: 1) an eﬀective anterograde refractory period
of both pathways and the atrioventricular node during IAP before PR
becomes greater than the RR interval (n= 17); 2) a reproductive single
retrograde junctional echo beat (n= 6) during IAP and permanent in-
duction of sustained AVNRT during IAP (n= 4); and 3) repetitive atrial
ﬁbrillation induction during IAP (n= 1). Permanent reproducible in-
duction of orthodromic atrioventricular reentrant tachycardia (OAVRT)
was documented in one case of double tachycardia (coincident with
OAVRT and typical slow-fast AVNRT) during IAP, which prevented us
from evaluating PR/RR. PR/RR > 1 was observed only after left-sided
concealed accessory pathway ablation, but a reproducible jump and
induction of typical slow-fast AVNRT were achieved only after iso-
proterenol infusion.
The mean maximum PR/RR ratio decreased signiﬁcantly to
0.76 ± 0.14 after slow pathway ablation and to 0.74 ± 0.14 after
modiﬁcation (p=NS between groups, and P < 0.00001 as compared
to the maximum value prior to ablation). The absence of a PR/RR ratio
≥1 was documented in 99.6% of cases of AVNRT after slow pathway
ablation or modiﬁcation with and without isoproterenol infusion. In
contrast, slow pathway ablation (no jump during programmed atrial
stimulation with up to 3 extra stimuli and isoproterenol infusion) was
documented less frequently (61% (140/228) cases, p < 0.001 as
compared to the absence of PR/RR≥ 1).
In the subgroup of children (AVNRT: n= 60, age: 14.0 ± 3.0, 58%
girls; controls: n= 58, age: 14.3 ± 3.1, P=NS, 39% girls, p=NS,
96% OAVRT), the mean maximum PR/RR ratios prior to ablation were
1.14 ± 0.25 in the AVNRT group vs. 0.80 ± 0.12 in the control group
(P < 0.0001). In the AVNRT group, PR/RR≥ 1 was present in 80.0%
before ablation (48/60, in 6 cases after isoproterenol) and in 1.6% (1/
60) after ablation. In the control group, there were no cases of PR/RR
ratio ≥1.
In symptomatic patients, recurrences of AVNRT were referred for
additional procedures (n=6). During the second procedure, re-
currences of PR/RR≥ 1 were revealed despite the conﬁrmation of its
absence during the observation period with IAP and isoproterenol
challenge after the ﬁrst ablation. Among the entire study group, only 2
patients had a reproducible PR/RR≥ 1 without a jump and AVNRT
induction. In these cases, the ﬁrst and third applications of thermal
mapping with junctional beats induced sustained typical AVNRTs.
Therefore, PR/RR ratio validation was determined as an end-point for
slow pathway ablation in these cases. In our current practice, PR/
RR≥ 1 during IAP from the PCS with or without isoproterenol infusion
in patients with documented narrow QRS tachycardia (and no other
mechanisms of tachycardia) has become an additional indicator for SP
ablation, despite the lack of a typical jump or inducibility of AVNRT
during EPS.
4. Discussion
The results showed that PR/RR≥ 1 during IAP from the PCS is
associated with the presence of anterograde SSPC and predicts the in-
ducibility of AVNRT in both children and adults. The use of this sim-
pliﬁed approach for validating SSPC may have important implications
for fast and easy testing before and after the ablation of AVNRT. PR/RR
ratio≥1 during IAP from PCS may be an additional indication or a pure
single end-point for successful slow pathway ablation, even in patients
with non-inducible AVNRT, without dual atrioventricular physiology,
and after isoproterenol infusion. Moreover, it may predict recurrences
of AVNRT, despite non-inducibility of arrhythmia.
We have reported that PR > RR during IAP represents continuous
conduction via the slow pathway.
There were not attempts for fast pathway ablation therefore the
conclusion on impact of fast pathway ablation on PR/RR can not be
provided.
Despite being a common focus of many studies, the diagnosis of
AVNRT and the electrophysiological properties of the AVNRT substrate
remain challenging and not completely clear. The rate of typical jump
after S2 in patients with AVNRT is reported to be 60 to 80% and is less
common in younger patients. On the other hand, in some pediatric
populations without AVNRT, the incidence of the classic deﬁnition of
jump after S2 (an increase of 40–50ms within S2) is reported to be
20–40% [4–9]. Moreover, ECGs recorded in an episode of narrow QRS
tachycardia in pediatric patients are unreliable for diﬀerential diag-
nosis, which makes the diagnosis in this group much more challenging
[14].
Autonomic tone balance, hormonal imbalance, and sedation may
play important roles in the inducibility of AVNRT and the character-
istics of slow pathway conduction [3–5]. Sometimes, only thermal
mapping of the slow pathway region or atypical maneuvers may induce
sustained AVNRT and a reproducible, conﬁrmed diagnosis after addi-
tional maneuvers or mapping techniques [11,12,14,15]. In our study,
the incidence of standard jumps was about 50%, which increased sig-
niﬁcantly when S3 and S4 were accepted with aggressive pacing pro-
tocols and isoproterenol challenge.
The PR/RR ratio evaluation has been incorporated into the elec-
trophysiological diagnosis of AVNRT and guidelines for ablation [4–9].
In patients with and without jumps, the PR/RR ratio may be used as a
simple method to evaluate the eﬀects of radiofrequency energy after
applications to the slow pathway. In patients without a typical jump
and non-inducibility of AVNRT, the PR/RR ratio may be the only reli-
able method for determining the presence of the slow pathway. More-
over, some data suggest that non-inducibility of AVNRT after ablation
Table 3
Diagnostic performance of various parameters of atrioventricular conduction during PCS pacing in patients with AVNRT and controls.
AVNRT
n=228
Control
n=170
Sensitivity Speciﬁcity PPV NPV
+ − + −
Baseline standard „jump” 112 116 15 155 49% (CI: 42–56) 91% (CI:86–95) 88 % (CI: 82–92) 57% (CI:54–60)
Baseline combine „jump” 170 58 20 150 75% (CI:68–80) 88% (CI:82–93) 89% (CI:85–93) 72% (CI:67–76)
Baseline PR/RR≥ 1 174 54 4 166 76% (CI:70–82) 98% (CI: 94–99) 98% (CI:94–99) 75% (CI: 71–80)
Isoproterenol challenge standard „jump” 119 107 22 148 53% (CI:46–59) 87% (CI:81–92) 84% (CI:78–89) 58% (CI:54–62)
Isoproterenol combine „jump” 182 46 25 145 80% (CI:74–85) 85% (CI:79–90) 88% (CI:83–91) 76% (CI:71–80)
Isoproterenol PR/RR≥ 1 200 28 7 163 88% (CI:83–92) 96% (CI:92–98) 97% (CI:93–98) 85% (CI:85–89)
Abbreviations: AVNRT – atrioventricular nodal reentrant tachycardia; PPV – positive predictive values; NPV – negative predictive values; CI – conﬁ-dence interval; PR/RR – PR interval to
RR interval ratio: from the atrial stimulus to earliest R wave on ECG during incremental atrial pacing.
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with a remaining PR/RR ratio ≥1 may be associated with the risk of
AVNRT recurrence. From a practical point of view, evaluating the SSPC
should have priority when performing an atrial pacing protocol before
and after SVT ablation and with the administration of isoproterenol
[4–9].
Previous techniques for PR/RR ratio measurements required HRA
pacing and several QRS complexes with a continuous occurrence of
PR > RR. However, our simpliﬁed approach (Table 2) enables easy
detection of PR/RR ratios≥1 using just a single pacing spike in front of
the QRS complex during IAP from the PCS. Therefore, in a majority of
cases, observations did not even require oﬀ-line or review screen
measurements, and they were visible to operators when watching IAP
continuously on-line on a screen (Fig. 1–3). On contrary, the study of
Baker was performed in selected, small group of patients and was done
in time-consuming protocol [6]. Our study validate new site of pacing
and easier method of identiﬁcation of PR > RR in a large group of
patients.
Several inputs of AVN (especially in children) may share the same
electrophysiological properties during incremental atrial pacing as slow
pathway. Therefore, evaluation of PR/RR≥ 1 should be combined with
other diagnostic maneuvers.
This technique may be very attractive for the growing number of
cryoablation cases and non-inducible cases often reported in pediatric
populations [2,16,17]. The catheter tip adheres to the endocardium
during cryomapping and cryoablation, which prevents catheter dis-
lodgement. Moreover, junctional rhythms are not common during
cryoablation, so the eﬀectiveness of cryoablation cannot be evaluated
easily. Cryoablation is associated with deﬁnitive prolongation of the
procedure and higher rates of recurrence [2,16,17]. Therefore, IAP
from the PCS and evaluation of the PR/RR ratio (even after iso-
proterenol infusion with a stable frozen catheter position) may be used
as a direct method for evaluating SSPC during 4–6min of a single
cryoapplication. The time to change the PR/RR ratio during the ﬁrst
minute of cryoablation may indicate an important target for additional
cryoapplication, but a prospective evaluation of this approach is
needed.
Previous studies used complicated approaches for PR/RR ratio
evaluation. Up to 4 catheters were used, only high right atrium pacing
was performed, the IAP protocol was time-consuming, and a limited
number of controls were evaluated in the selected AVNRT patient
groups. Moreover, there has been no standard evaluation of iso-
proterenol (Table 2). Our approach clearly simpliﬁes the procedure and
makes it fast and easily reproducible for a variety patient populations
and approaches (children, two-catheter approach, non-ﬂuoroscopic
approach) (5–9). Moreover, PR/RR≥ 1 was also observed before slow
pathway ablation but not longer after in all patients with a familial
form of AVNRT. Therefore, there may be an association with the genetic
substrate for this arrhythmia [18].
4.1. Limitations
One of the limitations of this study is that groups were not matched
for several clinical factors that may inﬂuence the results. Typically, only
narrow QRS tachycardia should be compared, but such cases were re-
presented with the highest numbers, and the results were consistent
among subgroups (children and induced SVT). No prospective evalua-
tion of the PR/RR ratio was performed after each application, so suc-
cessful and unsuccessful application sites cannot be compared.
Recurrences of PR/RR > =1 during observation period often
proceeded recurrences of inducibility of AVNRT and need for additional
application. However, those observations were not consistently eval-
uated and they are insuﬃcient for predicting further recurrences.
Recurrences of PR/RR > =1 were not evaluated invasively in late
follow-up in asymptomatic patients.
Moreover, our approach and the PR/RR interval measurement
during IAP were not directly compared with HRA pacing and a
multicatheter approach. Despite the inducibility of a typical jump or
AVNRT at baseline, not all patients were given isoproterenol. Therefore,
the direct impact of isoproterenol on the PR/RR ratio in all AVNRT
cases prior to ablation was not evaluated. Current pediatric guidelines
reported that eliminating SSPC (PR/RR > 1) using radiofrequency
ablation or cryoablation when it is initially present also appears to re-
duce recurrences and is an acceptable endpoint [4,19,20].
5. Conclusions
This study demonstrated the following: (1) a standard jump was
present less frequently at baseline and after isoproterenol challenge
than PR/RR ratio ≥1 during IAP; (2) isoproterenol infusion sig-
niﬁcantly increased the incidence of PR/RR ratio ≥1 during IAP; (3)
successful catheter ablation was more frequently associated with the
elimination of PR/RR≥ 1 during IAP with and without isoproterenol
challenge than elimination of DAVN; and (4) the presence and recur-
rence of PR/RR≥ 1 during IAP within the same procedure or further
procedures indicate a residual substrate for tachycardia, despite an
inability to induce tachycardia. A PR/RR ratio ≥1 during IAP from
PCS, even without a jump and AVNRT induction, may serve as an in-
dicator and end-point of ablation in selected patients with documented
narrow QRS tachycardia and the exclusion other substrates. Finally, the
absence of SSPC with PR < RR within IAP from the PCS in AVNRT
patients may have appeared due to the reproduction echo beats, per-
manent AVNRT inducibility, or the refractory period of atrioventricular
node.
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